Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years.
Repka
Michael X
MX
Kraker
Raymond T
RT
Beck
Roy W
RW
Atkinson
C Scott
CS
Bacal
Darron A
DA
Bremer
Don L
DL
Davis
Patricia L
PL
Gearinger
Matthew D
MD
Glaser
Stephen R
SR
Hoover
Darren L
DL
Laby
Daniel M
DM
Morrison
David G
DG
Rogers
David L
DL
Sala
Nicholas A
NA
Suh
Donny W
DW
Wheeler
Maynard B
MB
D000293:Adolescent; D000550:Amblyopia / Q000188:drug therapy* / Q000503:physiopathology; D002648:Child; D015259:Dopamine Agents / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage*; D008297:Male; D010865:Pilot Projects; D011446:Prospective Studies; D014792:Visual Acuity / Q000502:physiology
D015259:Dopamine Agents; D007980:Levodopa